BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

TEACHER

Joseph Liu

Session 13 – Advances in Cell & Gene Therapy

Date:29 July (Friday)
Time:  12:20 – 13:50 (GMT+8)

Joseph Liu

Commercial Head, Cell & Gene Therapy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd.

More than 20 years’ experience in pharmaceutical industry, currently as the Commercial Head of Cell & Gene Therapy in Novartis Asia Pacific managing the C&G business in Asia Pacific countries including S. Korea, Taiwan, Singapore and Hong Kong. Started the pharma career as the medical representative in Taipei City and went through different positions in the country, region and global; Taiwan, Singapore and S. Korea; MSD and Novartis. 

Speech title & Synopsis

Reimaging the future of Cancer Care, the Asia Pacific Experience

Introducing Novartis C&G, our mission, roadmap and milestone in the journey. Share the insights of our business model and operation, and the learning from the past 2 years in Asia Pacific region. Our plan how to support patients better in the C&G therapies and the information of T-Charge, our new CAR-T platform.